These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10385255)

  • 1. Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.
    Lindström E; Björkqvist M; Håkanson R
    Br J Pharmacol; 1999 May; 127(2):530-6. PubMed ID: 10385255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
    Håkanson R; Ding XQ; Norlén P; Lindström E
    Regul Pept; 1999 Mar; 80(1-2):1-12. PubMed ID: 10235629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
    Ding XQ; Lindström E; Håkanson R
    Br J Pharmacol; 1997 Sep; 122(1):1-6. PubMed ID: 9298521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity.
    Ding XQ; Lindström E; Håkanson R
    Pharmacol Toxicol; 1997 Nov; 81(5):232-7. PubMed ID: 9396089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells.
    Ding XQ; Lindström E; Håkanson R
    Pharmacol Toxicol; 1997 Jul; 81(1):19-25. PubMed ID: 9258980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
    Ding XQ; Håkanson R
    Pharmacol Toxicol; 1996 Sep; 79(3):124-30. PubMed ID: 8884870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells. A histochemical, electron-microscopic and chemical study.
    Chen D; Zhao CM; Norlén P; Björkqvist M; Ding XQ; Kitano M; Håkanson R
    Cell Tissue Res; 2000 Jan; 299(1):81-95. PubMed ID: 10654072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of gastrin in the development of gastric mucosa, ECL cells and A-like cells in newborn and young rats.
    Björkqvist M; Dornonville de la Cour C; Zhao CM; Gagnemo-Persson R; Håkanson R; Norlén P
    Regul Pept; 2002 Oct; 108(2-3):73-82. PubMed ID: 12220729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.
    Kitano M; Norlén P; Ding XQ; Nakamura S; Håkanson R
    Br J Pharmacol; 2000 Jun; 130(3):699-705. PubMed ID: 10821801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversibility of cholecystokinin-B/gastrin receptor blockade: a study of the gastrin-ECL cell axis in the rat.
    Norlén P; Lindström E; Ding XQ; Kitano M; Håkanson R
    Pharmacol Toxicol; 1999 Apr; 84(4):159-64. PubMed ID: 10227066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological analysis of CCK(2) receptor ligands using COS-7 and SK-N-MC cells, expressing the human CCK(2) receptor.
    Nilsson I; Monstein HJ; Lindström E; Håkanson R; Svensson S
    Regul Pept; 2002 Jan; 103(1):29-37. PubMed ID: 11738246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells.
    Lindström E; Björkqvist M; Boketoft A; Chen D; Zhao CM; Kimura K; Håkanson R
    Regul Pept; 1997 Aug; 71(2):73-86. PubMed ID: 9416989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine depletion does not affect pancreastatin secretion from isolated rat stomach ECL cells.
    Lindström E; Norlén P; Håkanson R
    Eur J Pharmacol; 2000 Jan; 387(1):19-25. PubMed ID: 10633155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandins inhibit secretion of histamine and pancreastatin from isolated rat stomach ECL cells.
    Lindström E; Håkanson R
    Br J Pharmacol; 1998 Jul; 124(6):1307-13. PubMed ID: 9720805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohormonal regulation of secretion from isolated rat stomach ECL cells: a critical reappraisal.
    Lindström E; Håkanson R
    Regul Pept; 2001 Mar; 97(2-3):169-80. PubMed ID: 11164953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
    Ding XQ; Håkanson R
    Pharmacol Toxicol; 1996 Dec; 79(6):324-30. PubMed ID: 9000260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric submucosal microdialysis: a method to study gastrin- and food-evoked mobilization of ECL-cell histamine in conscious rats.
    Kitano M; Norlén P; Håkanson R
    Regul Pept; 2000 Jan; 86(1-3):113-23. PubMed ID: 10672910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K
    Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
    Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
    J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation.
    Kidd M; Modlin IM; Black JW; Boyce M; Culler M
    Regul Pept; 2007 Oct; 143(1-3):109-17. PubMed ID: 17531331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.